Goldman Sachs Group Inc. Buys 28,226 Shares of Afya Limited $AFYA

Goldman Sachs Group Inc. increased its holdings in Afya Limited (NASDAQ:AFYA) by 167.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,093 shares of the company’s stock after acquiring an additional 28,226 shares during the period. Goldman Sachs Group Inc.’s holdings in Afya were worth $809,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Doma Perpetual Capital Management LLC grew its holdings in shares of Afya by 4.4% in the first quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company’s stock valued at $10,619,000 after acquiring an additional 25,111 shares in the last quarter. Two Sigma Advisers LP lifted its stake in Afya by 27.2% in the fourth quarter. Two Sigma Advisers LP now owns 78,600 shares of the company’s stock valued at $1,248,000 after purchasing an additional 16,800 shares during the last quarter. Wellington Management Group LLP purchased a new position in Afya in the fourth quarter valued at approximately $829,000. Northern Trust Corp lifted its stake in Afya by 109.7% in the fourth quarter. Northern Trust Corp now owns 40,054 shares of the company’s stock valued at $636,000 after purchasing an additional 20,957 shares during the last quarter. Finally, Cerity Partners LLC purchased a new position in Afya in the first quarter valued at approximately $476,000. 88.02% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on AFYA shares. UBS Group upgraded Afya from a “neutral” rating to a “buy” rating and lowered their price objective for the stock from $19.50 to $19.00 in a research report on Monday, September 8th. Morgan Stanley set a $17.50 target price on Afya and gave the stock an “overweight” rating in a research note on Wednesday, August 6th. Zacks Research raised Afya to a “hold” rating in a research report on Friday, August 8th. Wall Street Zen raised Afya from a “buy” rating to a “strong-buy” rating in a research report on Saturday, September 13th. Finally, Citigroup raised Afya from a “sell” rating to a “neutral” rating and cut their price objective for the company from $16.00 to $14.00 in a research report on Tuesday, July 29th. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Afya currently has a consensus rating of “Hold” and a consensus target price of $18.20.

Afya Trading Up 0.7%

Shares of NASDAQ AFYA opened at $16.17 on Wednesday. The business’s 50 day moving average is $15.04 and its two-hundred day moving average is $16.94. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.94 and a quick ratio of 0.94. Afya Limited has a 1-year low of $13.47 and a 1-year high of $19.90. The stock has a market capitalization of $1.52 billion, a P/E ratio of 12.25, a PEG ratio of 0.48 and a beta of 0.56.

Afya Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.